title: Diagnosis and treatment of 106 cases of human brucellosis.
abstract: During the year 1987, 106 cases of human brucellosis were studied prospectively at the Jordan University Hospital. The disease was more often diagnosed among adults (73.6%) than children (26.4%). Serious clinical complications were observed in 5.7% patients. An initial Brucella antibody titre greater than or equal to 160 proved to be reliable in confirming suspected cases of acute and subacute brucellosis. Culture of blood was found to be more sensitive (44.4%) and significant (P less than 0.02) than bone marrow culture (27.7%) for detecting Brucella melitensis. All patients treated with rifampicin plus tetracycline or co-trimoxazole were considered to be clinically cured by disappearance of all major clinical features of brucellosis. By contrast, 2/10 patients treated with rifampicin alone, as well as 1/56 patients treated with tetracycline and streptomycin, clinically relapsed. It is evident from this study that the treatment with rifampicin alone is not as effective in brucellosis as it is when given with another appropriate drug.
authors.affiliation: Department of Microbiology, University of Jordan, Faculty of Medicine, Amman.
authors.forename: A
authors.initials: A
authors.lastname: Shehabi
authors.forename: K
authors.initials: K
authors.lastname: Shakir
authors.forename: M
authors.initials: M
authors.lastname: el-Khateeb
authors.forename: H
authors.initials: H
authors.lastname: Qubain
authors.forename: N
authors.initials: N
authors.lastname: Fararjeh
authors.forename: A R
authors.initials: AR
authors.lastname: Shamat
mesh_terms: D000328:Adult; D002006:Brucellosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012074:Remission Induction; D012293:Rifampin / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use*
chemical_list: D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D013752:Tetracycline; D012293:Rifampin